Program

Event format

The symposium will be hybrid and bilingual with simultaneous translation, so you can follow all the information without loss.

Friday, 06.12.2024

Saturday, 07.12.2024

Friday, 06.12.2024

Saturday, 07.12.2024

Cookie Consent Banner von Real Cookie Banner

08:45	OPENING	M. Schostak, Magdeburg, DE
08:50	PROSTATE CANCER 1 Modern Screening and Staging	Moderation: M. Schostak, Magdeburg, DE \| A. Borkowetz, Rostock, DE
08:50	State-of-the-Art: Biomarkers in early Detection	A. Borkowetz, Rostock, DE
09:03	Hot Topics: Techniques in comparison bpMRI vs. mpMRI	T. Franiel, Jena, DE
09:15	mpMRI vs. ExactVu	L. Klotz, Toronto, CA
09:27	Very Hot Topic: transrectal vs. transperitoneal biopsy	D. Pfister, Köln, DE
09:41	State-of-the-Art: Strengths & Weakness of PSMA-PET/CT	M. Eiber, München, DE
09:54	State-of-the-Art: Genetic Diagnostics	K. Riehm, Köln, DE
10:07	BREAK
10:30	UROTHELIAL CARCINOMA 1 Urinary bladder locally limited	Moderation: J. Schittko, Magdeburg, DE \| B. Osmonov, Lübeck, DE
10:30	Case presentation: pT1 HG pL0 pV0, 2.4cm, no pTis	F. Seelemeyer, Köln, DE
10:32	MRI instead of (re-)TUR The New MRI-Pathway	J. Fütterer, Nijmegen, NL
10:42	TUR is indispensable	J. Gschwend, München, DE
10:52	Discussion
10:57	State-of-the-Art: Best Imaging for Bladder Cancer	J. Fütterer, Nijmegen, NL
11:10	State-of-the-Art: Extended Lymphadenectomy in Radical Cystectomy	J. Gschwend, München, DE
11:23	Hot Topic: Radical cystectomy – impact of centres	M. Schrader, Berlin, DE
11:35	State-of-the-Art: New Intravesical Therapies	C. Rieger, Köln, DE
11:48	PROSTATE CANCER 2 Focal Therapy	Moderation: M. Schostak, Magdeburg, DE \| L. Klotz, Toronto, CA
11:48	State-of-the-Art: Focal Therapy – Status 2024	L. Klotz, Toronto, CA
12:01	Semi-Live HIFU	A. Fehr, Magdeburg, DE
12:11	IRE:	F. Colletini, Berlin, DE
12:21	TULSA-PRO	L. Halbe, Köln, DE
12:31	Laserablation	S. Blaschke, Magdeburg, DE
12:41	Focal HDR-Brachytherapy	F. Fischbach, Magdeburg, DE
12:51	LUNCH BREAK
13:40	UROTHELIAL CARCINOMA 2 Local advanced	Moderation: P. Paffenholz, Köln, DE \| A. Stenzl, Stuttgart, DE
13:40	Case Presentation: MIBC cT3 Cn0 cM0	M. Lehmann, Köln, DE
13:42	Hot Topic: Neoadjuvant Standard Gem/Cis or ddMVAC ?	P. Ivanyi, Hannover, DE
13:54	State-of-the-Art: adj: Immuntherapy – ready for Prime-Time?	A. Lorch, Zürich, CH
14:07	Hot Topic: radical Cystectomy – impact of centers	Mark Schrader, Berlin, DE
14:19	SATELLITE SYMPOSIUM 1: UROTHELIAL CANCER
15:05	UROTHELIAL CARCINOMA 3 Urinary bladder locally limited	Moderation: R. Weiten, Köln, DE \| U.-B. Liehr, Magdeburg, DE
15:05	Case Presentation: High-Grade MIBC in a very young man	F. Wallstab, Magdeburg, DE
15:07	Paneldiscussion Radical Surgery (+neoadj. Therapy)	B. Osmonov, Lübeck, DE
15:15	Trimodal therapy, radiation + immunotherapy	O. Ott, Erlangen, DE
15:23	Partial Resection + Lymphadenectomy	P. Nuhn, Kiel, DE
15:31	Discussion
15:39	State-of-the-Art: Sexual function preserving Procedures in Women	A. Stenzl, Stuttgart, DE
15:52	BREAK
16:20	PROSTATE CANCER 3 Organ confined	Moderation: F. Seseke, Halle, DE \| L. Klotz, Toronto, CA
16:20	Case Presentation: PSA-Density >0.3; PIRADS 5	J. Vogt, Magdeburg, DE
16:22	Pro-und-Con: Therapy without Biopsy? Pro (Biopsy is dispensable)	M. Chaloupka, München, DE
16:32	Con (Biopsy is necessary)	A. Blana, Fürth, DE
16:42	Discussion
16:47	Case Presentation: ISUP 2, PSA 14.3 ng/ml, 4/4 Index positive, Vol. 162 ml	O. Steenbock, Köln, DE
16:49	Paneldiscussion: Radical Prostatectomy	F. Wawrochek, Oldenburg, DE
16:57	Laserenucleation + HIFU or AS	H. Cash, Berlin, DE
17:05	Discussion
17:13	SATELLITE SYMPOSIUM: PROSTATE CANCER 2
17:58	UROTHELIAL CANCER 4 Utuc	Moderation: F. Wawrochek, Oldenburg, DE \| F. Seseke, Halle, DE
17:58	Case Presentation: Z.n. RCX, GFR 80, now 2 cm HG UTUC	K. Al-Assali, Magdeburg, DE
18:00	Paneldiscussion Nephroureterectomy	M. Pallauf, Salzburg, AT
18:10	Organ preserving approach	U.-B. Liehr, Magdeburg, DE
18:20	Discussion
18:28	PENILE CANCER	Moderation: F. Wawrochek, Oldenburg, DE \| F. Seseke, Halle, DE
18:28	State-of-the-Art: Second Line Therapy	B. Ayres, London, UK
18:41	PROSTATE CANCER 4 Metastatic Prostate Cancer	Moderation: A. Heidenreich, Köln, DE \| M. Schostak, Magdeburg, DE
18:41	Hot Topic: SPARC Consensus on Lutetium-Response	A. Bjartell, Malmö, SE
18:53	END OF DAY 1

08:15	OPENING	M. Schostak, Magdeburg, DE
08:20	RENAL CANCER 1 Modern Staging	Moderation: J. Bedtke, Stuttgart, DE \| T. Klatte, Bad Saarow, DE
08:20	Hot Topics: When do we need a biopsy?	H. Reis, Frankfurt/Main, DE
08:32	New imaging for cystic tumors	A. Hötker, Zürich, CH
08:44	Localized disease Hot Topics: „Partial Nephrectomy – always Off-Clamp and (almost) always organ-preserving!“	G. Simone, Rom, IT
08:56	SATELLITE SYMPOSIUM 3: KIDNEY CANCER
09:41	BREAK
10:05	PROSTATE CANCER 5 Lymphadenectomy	Moderation: G. Simone, Rom, IT \| A. Blana, Fürth, DE
10:05	Case presentation: PSA 9 ng/ml, cT1c, ISUP 2 (52% Cores with High Grade)	J. Heidenreich, Köln, DE
10:07	Pro und Con: Bury Lymphadenectomy Pro (No Lymphadenectomy)	D. Tilki, Hamburg, DE
10:17	Contra (Lymphadenectomy!)	A. Heidenreich, Köln, DE
10:27	Discussion
10:32	State-of-the-Art: New Standards in Radiation for High Risk PCA	U. Ganswindt, Innsbruck, AT
10:45	Recurrence
10:45	Case presentation: High Risk biochemical relapse, negative PSMA-PET/CT	J. Seifert, Magdeburg, DE
10:47	Paneldiscussion Radiation + ADT	N.-S. Schmidt-Hegemann, München, DE
10:55	Systemic Treatment alone	M. Schostak, Magdeburg, DE
11:03	Guideline View and Conclusion	D. Tilki, Hamburg, DE
11:11	Discussion
11:19	RENAL CANCER 2 Locally advanced / metastatic	Moderation: P. Paffenholz, Köln, DE \| G. Gakis, Halle, DE
11:19	State-of-the-Art: Lymphadenectomy at High Risk RCC?!	S. Siemer, Homburg, DE
11:32	Case presentation: Oligometastatic RCC	B. Ahmad, Magdeburg, DE
11:35	Paneldiscussion New Imaging	A. Hötker, Zürich, CH
11:43	Metasectomy/ablation	T. Klatte, Bad Saarow, DE
11:51	Sterotactic Radiation Therapy	U. Ganswindt, Innsbruck, AT
11:59	cytoreductive Nephrectomy	J. Bedke, Stuttgart, DE
12:07	Discussion
12:15	SATELLITE SYMPOSIUM 4: KIDNEY CANCER
13:00	LUNCH BREAK
13:45	SEMI-LIVE PROSTATE CANCER Prostate Cancer – RALP – different approaches in comparison	Moderation: D. Pfister, Köln, DE \| D. Tilki, Hamburg, DE
13:45	Transperitoneal Approach	J. Witt, Düsseldorf, DE
13:55	Retzius-sparing Approach	K. Fransis, Antwerpen, BE
	PENILE AND TESTICULAR CANCER	Moderation: D. Pfister, Köln, DE \| D. Tilki, Hamburg, DE
14:05	Inguinal Sentinel-Lymphadenectomy	B. Ayres, London, UK
14:15	URETHRAL CANCER	Moderation: D. Pfister, Köln, DE \| D. Tilki, Hamburg, DE
14:15	State-of-the-Art: Diagnostics & Therapy	G. Gakis, Halle, DE
14:28	CONCLUSION AND OUTLOOK FOR 2025	A. Heidenreich, Köln, DE
14:33	END OF DAY 2